NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 119 filers reported holding NURIX THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $453,695 | -76.6% | 57,722 | -70.3% | 0.00% | – |
Q2 2023 | $1,941,866 | +39.6% | 194,381 | +24.1% | 0.00% | – |
Q1 2023 | $1,391,132 | +208.5% | 156,659 | +281.5% | 0.00% | – |
Q4 2022 | $450,905 | -65.6% | 41,066 | -59.2% | 0.00% | – |
Q3 2022 | $1,312,000 | +45.3% | 100,753 | +41.4% | 0.00% | – |
Q2 2022 | $903,000 | -30.4% | 71,275 | -23.0% | 0.00% | – |
Q1 2022 | $1,297,000 | -46.5% | 92,563 | +10.4% | 0.00% | – |
Q4 2021 | $2,426,000 | +154.6% | 83,828 | +163.5% | 0.00% | – |
Q3 2021 | $953,000 | +32.0% | 31,811 | +16.9% | 0.00% | – |
Q2 2021 | $722,000 | -59.2% | 27,215 | -52.2% | 0.00% | – |
Q1 2021 | $1,770,000 | – | 56,918 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 1,822,883 | $14,327,860 | 1.60% |
DAFNA Capital Management LLC | 556,695 | $4,375,623 | 1.36% |
Redmile Group, LLC | 2,848,827 | $22,391,780 | 1.06% |
Deep Track Capital, LP | 2,997,830 | $23,562,944 | 0.91% |
WestHill Financial Advisors, Inc. | 283,333 | $2,226,997 | 0.65% |
Soleus Capital Management, L.P. | 814,000 | $6,398,040 | 0.59% |
Affinity Asset Advisors, LLC | 250,000 | $1,965,000 | 0.55% |
Boxer Capital, LLC | 1,224,892 | $9,627,651 | 0.51% |
AtonRa Partners | 24,227 | $190,424 | 0.40% |
WASATCH ADVISORS LP | 3,564,616 | $28,017,882 | 0.18% |